Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Vernalis and Biogen Idec collaborate on adenosine A2A receptor antagonists

July 1, 2004

Preclinical and clinical evidence for the efficacy of transdermal rotigotine in PD

June 30, 2004

ACR-16 reported safe as adjunct therapy in patients with advanced PD

June 30, 2004

Stalevo reported safe and effective in improving motor fluctuations in PD patients

June 30, 2004

FDA lifts clinical hold on ocinaplon

June 30, 2004

Gepirone ER NDA deemed not approvable

June 30, 2004

Results of recent Lexapro pediatric study

June 30, 2004

Study suggests simvastatin can prevent silent brain infarct

June 29, 2004

Repinotan study results reported at World Stroke Congress

June 29, 2004

Study parameters affect preclinical outcomes with neuroprotective agents

June 29, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...